Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Chi-Fai Ng"'
Autor:
Jeffrey S. K. Chan, Pias Tang, Jeremy M. Ho Hui, Yan H. A. Lee, Edward C. Dee, Kenrick Ng, Kang Liu, Gary Tse, Chi Fai Ng
Publikováno v:
The Prostate. 82:1477-1480
Although androgen deprivation therapy has known cardiovascular risks, it is unclear if its duration is related to cardiovascular risks. This study thus aimed to investigate the associations between gonadotrophin-releasing hormone (GnRH) agonist use d
Autor:
Vinson Wai-Shun Chan, Aqua Asif, Jasmine Sze-Ern Koe, Alexander Ng, Chi Fai Ng, Jeremy Yuen-Chun Teoh
Publikováno v:
Current Opinion in Urology. 32:311-317
The Coronavirus disease 2019 (COVID-19) pandemic has led to uncertainty on the optimal management for prostate cancer (PCa). This narrative review aims to shed light on the optimal diagnosis and management of patients with or suspected to have PCa.Fa
Autor:
Hao Zeng, Chi-Fai Ng, Jeremy Yuen-Chun Teoh, Yu Wei, Guangxi Sun, Peter Ka-Fung Chiu, Beihe Wang, Dingwei Ye, Bo Dai, Xiaojian Qin, Jian Pan, Hualei Gan, Guowen Lin, Yao Zhu, Fangning Wan, Cai-Yun He, Junlong Wu, Yuchao Ni, Fangjian Zhou, Yonghong Li
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:54-62
Background: Although China accounts for 7.8% of worldwide new prostate cancer (PCa) cases and 14.5% of new deaths according to GLOBOCAN 2020, the risk of PCa associated with germline mutations is poorly defined, hampered in part by lack of nationwide
Autor:
Peter Ka-Fung Chiu, Jeffrey J. Leow, Chih-Hung Chiang, Mok, Alex, Kai Zhang, Po-Fan Hsieh, Yao Zhu, Wayne Lam, Woon-Chau Tsang, Yu-Hua Fan, Tzu-Ping Lin, Tsz-Yeung Chan, Yuen-Chun Teoh, Jeremy, Peggy Sau-Kwan Chu, Gang Zhu, Ding-Wei Ye, Hsi-Chin Wu, Teck-Wei Tan, Hok-Leung Tsu, James, Chi-Fai Ng
Publikováno v:
Journal of Urology; Jul2023, Vol. 210 Issue 1, p88-98, 10p
Autor:
Jeremy Yuen-Chun Teoh, See-Ming Hou, Peter Ka-Fung Chiu, Siu-Ying Yip, Chi-Hang Yee, Monique J. Roobol, Sebastiaan Remmers, Sui-Yan Lau, Chi-Ho Leung, Christy Wing-Hin Mak, Chi-Fai Ng, Alex Qinyang Liu
Publikováno v:
Prostate Cancer and Prostatic Diseases, 25(4). Nature Publishing Group
Background: Men with elevated prostate-specific antigen (PSA) and initial negative prostate biopsy may have risk of prostate cancer (PCa) in the future. The role of Prostate Health Index (phi) in determining future PCa risk has not been studied befor
Autor:
Chi-Ho Leung, Peter Ka-Fung Chiu, Cho-Lik Ho, Jeremy Yuen-Chun Teoh, Kup-Sze Choi, Guanjin Wang, Xiao Shen, Chi-Fai Ng
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:672-676
To investigate the value of machine learning(ML) in enhancing prostate cancer(PCa) diagnosis. Consecutive systematic prostate biopsies performed from Jan 2003–June 2017 were used as the training cohort, and prospective biopsies performed from July
Autor:
Yan Hiu Athena Lee, Jeremy Man Ho Hui, Jeffrey Shi Kai Chan, Kang Liu, Edward C. Dee, Kenrick Ng, Pias Tang, Gary Tse, Chi Fai Ng
Publikováno v:
The Prostate. 83(1)
This study aims to examine the associations between metformin use concurrent with androgen deprivation therapy (ADT) and mortality risks in Asian, diabetic patients with prostate cancer (PCa).This study identified diabetic adults with PCa receiving a
Autor:
Weijie Gao, Yuliang Wang, Shan Yu, Zhu Wang, Taiyang Ma, Andrew Man-Lok Chan, Peter Ka-Fung Chiu, Chi-Fai Ng, Dinglan Wu, Franky Leung Chan
Publikováno v:
Stem Cell Research & Therapy. 13
Background Accumulating evidence supports that prostate cancer stem-like cells (PCSCs) play significant roles in therapy resistance and metastasis of prostate cancer. Many studies also show that nitric oxide (NO) synthesized by NO synthases can funct
Autor:
de la Rosette, Jean, Dominguez-Escrig, Jose, Kai Zhang, Teoh, Jeremy, Barret, Eric, Casanova Ramon-Borja, Juan, Muir, Gordon, Bohr, Julia, de Reijke, Theo, Chi-Fai Ng, Chi-Ho Leung, Sanchez-Salas, Rafael, Laguna, Pilar
Publikováno v:
Journal of Urology; Feb2023, Vol. 209 Issue 2, p347-353, 7p
Publikováno v:
Circulation
BACKGROUND: The relative cardiovascular safety of gonadotropin-releasing hormone (GnRH) antagonists compared with GnRH agonists in men with prostate cancer and known atherosclerotic cardiovascular disease (ASCVD) remains controversial. METHODS: In th